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Abstract: Sea anemones produce proteinaceous toxins for predation and defense, including peptide
toxins that act on a large variety of ion channels of pharmacological and biomedical interest.
Phymanthus crucifer is commonly found in the Caribbean Sea; however, the chemical structure
and biological activity of its toxins remain unknown, with the exception of PhcrTx1, an acid-sensing
ion channel (ASIC) inhibitor. Therefore, in the present work, we focused on the isolation and
characterization of new P. crucifer toxins by chromatographic fractionation, followed by a toxicity
screening on crabs, an evaluation of ion channels, and sequence analysis. Five groups of toxic
chromatographic fractions were found, and a new paralyzing toxin was purified and named
PhcrTx2. The toxin inhibited glutamate-gated currents in snail neurons (maximum inhibition of 35%,
IC50 4.7 µM), and displayed little or no influence on voltage-sensitive sodium/potassium channels
in snail and rat dorsal root ganglion (DRG) neurons, nor on a variety of cloned voltage-gated ion
channels. The toxin sequence was fully elucidated by Edman degradation. PhcrTx2 is a new
β-defensin-fold peptide that shares a sequence similarity to type 3 potassium channels toxins.
However, its low activity on the evaluated ion channels suggests that its molecular target remains
unknown. PhcrTx2 is the first known paralyzing toxin in the family Phymanthidae.
Keywords: sea anemone; neutoxin; glutamate receptor; defensin-like fold; ion channels;
Phymanthus crucifer
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Key Contribution: This study shows the isolation, sequencing and pharmacological characterization
of PhcrTx2, the first known crab-paralyzing toxin from the sea anemone Phymanthus crucifer and
its family Phymanthidae. PhcrTx2 is a new member of the defensin-fold peptide family from
sea anemone.
1. Introduction
Sea anemones produce a large number of proteinaceous toxins for preying on small crustaceans
and fishes, and for defense against predators [1,2]. These toxins comprise mainly cytolysins,
protease inhibitors, and a large variety of peptides acting on sodium or potassium channels; more
recently, acid-sensing ion channel (ASIC) and TRPV1 channels toxins have also been discovered [1].
These peptide toxins are valuable pharmacological tools for studying the structure and function of
ion channels [2], which are involved in many physiological and pathological processes. Ion channels
constitute a primary site of action for many antiepileptic drugs, local anesthetics, migraine treatments,
antipsychotics and mood stabilizers, antiarrhythmics, antihypertensives, and oral hypoglycemic
agents [3].
The discovery of novel families of sea anemone peptide toxins [4–6] and the development of
“omics” studies [7–14] have revealed a large diversity of peptides in several species. In addition,
novel molecular scaffolds and post-translational modifications in sea anemone peptides have been
described [4,6,9,15]. However, the number of known sea anemone peptide toxins is still small,
considering the large variety of peptides expected from their whole peptidomes, and taking into
account that only a minor fraction of the total number of known species has been analyzed. Therefore,
many new peptide toxins or even new families of peptide toxins are expected to be discovered from
these organisms.
An approach often used for the discovery of sea anemone toxins is based on a well-known crab
bioassay [16–18], due to the sensitivity of crustaceans to sea anemone toxins. Crab bioassay-guided
purifications have allowed the discovery of more than 30 sea anemone toxins, most of them belonging
to different groups of sodium channel toxins [16,19–27]. A fewer number of peptides acting on
potassium channels, and also on targets to be elucidated, have been found by observations of toxicity
signs induced by injection to crabs. Such peptides remain to be functionally characterized on a variety
of tentative targets, not only voltage-gated ion channels, but also ligand-gated ion channels [2,21,28],
such as glutamate-gated ion channels. Glutamate is the excitatory neurotransmitter in the crustacean
neuromuscular junction [29]; therefore, it has been suggested that glutamate receptor antagonists
could also be found among sea anemone toxins [30]. However, to date, no peptide acting on
glutamate-gated ion channels has been characterized from sea anemones, in contrast with other
venomous animals such as cone snails [31] and spiders [32]. Phymanthus crucifer (Le Sueur, 1817)
is a species of sea anemone that commonly inhabits the Caribbean Sea. This species is known to
produce a large diversity of peptides [33]; however, only one peptide toxin has been characterized,
PhcrTx1, which is an acid-sensing ion channel inhibitor presenting an inhibitor cystine knot (ICK)
motif [6]. In this work, we performed a crab bioassay-guided chromatographic fractionation of the
aqueous extract obtained from the sea anemone P. crucifer. Several chromatographic fractions showing
crab-paralyzing activity were isolated, and a major paralyzing peptide (PhcrTx2) was purified and
sequenced. This toxin showed sequence similarity to defensin-like peptides that exhibit a variety
of biological activities, including crab toxicity and voltage-gated (sodium or potassium) channel
inhibition. PhcrTx2 represents the first known member of the defensin-fold family of polypeptides
isolated from the family Phymanthidae. This is the first study describing paralyzing toxins in this sea
anemone family.
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2. Results
2.1. Bioassay-Guided Purification of P. crucifer Toxins
The aqueous extract (350 mg/90 mL 0.1 mol/L ammonium acetate) obtained from 5 g of the
sea anemone homogenate showed crab-paralyzing activity, and was subjected to chromatographic
fractionation. Sephadex G-50 is a low-pressure medium that has been commonly used for the group
fractionation of complex samples such as sea anemone extracts, due to its suitable fractionation range
(1.5 kDa to 30 kDa) for the separation of the peptide fraction from proteins, and low molecular weight
compounds. The sample was fractionated by gel filtration on Sephadex G-50 M, and aliquots were
taken from every other fraction (every 20 mL) for toxicity screening purposes. Due to the large number
of crabs needed for determining the ED50 or LD50 of every toxic chromatographic fraction, and the
unavailability of such a number, we focused our efforts on characterizing the toxicity of only pure
compounds submitted to both chemical and pharmacological characterization. Unless stated otherwise,
three crabs were used per sample at the dose of 2000 µg/kg for biological activity screening after every
chromatographic step, and only those fractions that paralyzed all of the crabs were selected for further
purification/analysis. The crab-paralyzing activity was detected in the broad zone (elution volume
820–1460 mL) indicated in the chromatographic profile (Figure 1A). The low UV absorption of the
crab-paralyzing fractions from Sephadex G-50 at 280 nm (Figure 1A) indicated that these are composed
of low abundance peptides and proteins distributed within the fractionation range of Sephadex G-50.
In addition, the low efficiency and resolution of a low-pressure medium such as Sephadex G-50
produces broad overlapping peaks, which disfavors the appearance of any notable signals coming
from these low abundance molecules. As a result, these crab-paralyzing molecules, distributed within
a large elution volume range, yield a flat low UV absorption zone in the chromatographic profile.
On the other hand, the crab-paralyzing zone is located between two high intensity signals whose
components are mostly located out of the fractionation range of the column. Molecules eluting out
of the fractionation range (>30 kDa or <1.5 kDa), specifically near the void volume (550 mL) or the
total volume of the column (1825 mL), tend to be poorly resolved or not separated at all. Therefore,
their contributions to the UV absorption add up to yield a significant increase of signal intensity at
both sides of the crab-paralyzing zone in the Sephadex G-50 chromatographic profile.
The toxic fractions were pooled and applied to a Fractogel EMD SO3− 650 M cation-exchange
column (Figure 1B), and the non-retained fraction was subsequently applied to a Fractogel EMD
DEAE 650 M anion-exchange column (Figure 1C). For screening purposes, small aliquots were pooled
according to the following groups: fractions from 0–50 mL, 50–100 mL, 100–150 mL, 150–200 mL,
200–250 mL, 250–300 mL, 300–350 mL, and 350–400 mL elution volume. Only the pools 0–50 mL and
50–100 mL, which were from cation-exchange chromatography and anion-exchange chromatography,
respectively, paralyzed all of the crabs. Then, every single fraction (1 to 20) from these pools was
assayed, and those paralyzing all of the crabs were pooled as I, II, III, and IV (Figure 1B,C).
The crab-paralyzing fractions (I, II, III, and IV) from ion-exchange chromatography were
subsequently subjected to reversed-phase C18 HPLC (Figure 2A–D). The chromatographic fractions
from RPC18-HPLC were pooled according to peak shape, and assayed on crabs. A total of
16 toxic reversed-phase chromatographic fractions were separated and analyzed by MALDI-TOF-MS.
These toxic fractions were classified into five groups according to their chromatographic behavior,
molecular masses, and paralyzing effects on crabs (Table 1, Supplementary Table S1). A major
reversed-phase fraction (number 5 in Figure 2A) was subjected to repurification on an analytical
reversed-phase C18 column (Figure 2E,F), and the pure toxin was named PhcrTx2. The amount of pure
peptide was 420 µg, which represents the 0.0084% of 5 g P. crucifer freeze-dried whole homogenate.
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Table 1. Features overview of distinct groups of toxic reversed-phase chromatographic fractions, based
on chromatographic behavior, molecular masses, and crab-paralyzing activity. Three crabs were used
per sample for screening purposes. Only those samples provoking death or paralysis to all of the crabs
were considered lethal or paralyzing, respectively, at 2000 µg/kg.
RP-HPLC Fraction Number Features Paralyzing Effects on Crab Uca thayeri
1–4 and 6
tR = 25–30 min *
1986–5671 Da **
basic peptides ***
Progressive slowing down of legs movements
until remaining motionless approximately after
30 min. Lethal.
5 and 7
tR = 40–45 min
5294–5296 Da
basic peptides
Moderate tetanic paralysis starting after 30 min
from toxin administration. Partial recovery
from paralysis followed by uncoordinated leg
movements. Not lethal.
8
tR = 51 min
3082 Da
basic peptide
Severe tetanic paralysis after a few seconds,
resembling the effects provoked by Nav
toxins [27]. Lethal.
9–15
tR = 49–59 min
4573–9847 Da
acidic peptides
Severe tetanic paralysis after a few seconds,
resembling the effects provoked by Nav
toxins [27]. Lethal.
16
tR = 50–55 min
19,758 Da
acidic protein
Moderate tetanic paralysis 5 min after toxin
administration. Not lethal.
* In the reversed-phase HPLC separation. ** Measured by MALDI-TOF-MS (see Supplementary Table S1).
*** According to their retention in ion-exchange chromatography at pH 7: the basic peptides were retained in
the cation exchanger, whereas the acidic proteins and peptides were retained in the anion exchanger.
In a previous work [6], PhcrTx1, an acid-sensing ion channel toxin, was isolated using the same
conditions of gel filtration chromatography, cation-exchange chromatography, and reversed-phase
chromatography. Figure 1A shows the crab-paralyzing zone of the gel filtration chromatographic
profile, which almost completely excludes the ASICs inhibition zone from which PhcrTx1 was
previously isolated [6]. Also, Figure 1B shows that the crab-paralyzing zone (pools I and II) is totally
separated from the ASICs inhibition zone where PhcrTx1 was eluted [6]. Therefore, at this point after
the cation-exchange chromatography, PhcrTx1 and PhcrTx2 are completely separated. Figure 2A–F
show the retention time (*) of PhcrTx1 in similar conditions of reversed-phase chromatography,
indicating that PhcrTx2 is more strongly retained than PhcrTx1, in contrast with its behavior in
cation-exchange chromatography (pool I, Figure 1B), where it elutes much earlier than PhcrTx1
(ASICs inhibition, Figure 1B).
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Figure 1. (A) Gel filtration profile of P. crucifer aqueous extract. The soluble material contained in 5 
grams of whole-body homogenate (350 mg/90 mL) was fractionated on Sephadex G-50 (5 × 93 cm) at 
2 mL/min using 0.1 mol/L ammonium acetate. Fractions of 20 mL each were collected; those within 
the elution volumes of 820 mL to 1460 mL were paralyzing to all of the crabs, and were pooled; (B) 
Cation-exchange chromatographic profile of the crab-paralyzing pool of chromatographic fractions 
from Sephadex G-50, in Fractogel EMD SO3− 650 M (1.8 × 5 cm); (C) Anion-exchange chromatographic 
profile of the non-retained fraction from the cation exchanger, in Fractogel EMD DEAE 650 M (1.8 × 
5 cm). Both separations (B,C) were done at a flow rate of 1 mL/min using a 400-mL gradient, from 
0.01 mol/L to 1 mol/L ammonium acetate. Eighty fractions of 5 mL each were collected in every 
chromatographic separation. Dashed lines in the ion-exchange chromatographic profiles represent 
the gradient of ammonium acetate. Fractions exhibiting toxicity to crabs were named I, II, III, and IV. 
The pools of fractions that inhibited acid-sensing ion channels are shown in both gel-filtration and 
cation-exchange chromatographic profiles, according to previous results with the same P. crucifer 
homogenate, using identical conditions [6]. PhcrTx1, an acid-sensing ion channel toxin from P. crucifer 
[6], eluted inhibiting pools of chromatographic fractions in the ASICs, as shown in (A,B). As shown, 
the crab-paralyzing zone and the ASICs inhibition zone barely overlapped in the gel filtration profile 
(A); and completely separated from each other in the cation-exchange profile (B). PhcrTx1 is not 
present among the crab-paralyzing chromatographic fractions isolated from the ion-exchange 
chromatographic separations. 
Figure 1. (A) Gel filtration profile of P. crucifer aqueous extract. The soluble material contained in
5 grams of whole-body homogenate (350 mg/90 mL) was fractionated on Sephadex G-50 (5 × 93 cm)
at 2 mL/min using 0.1 mol/L ammonium acetate. Fractions of 20 mL each were collected; those
within the elution volumes of 820 mL to 1460 mL were paralyzing to all of the crabs, and were
pooled; (B) Cation-exchange chromatographic profile of the crab-paralyzing pool of chromatographic
fractions from Sephadex G-50, in Fractogel EMD SO3− 650 M (1.8 × 5 cm); (C) Anion-exchange
chromatographic profile of the non-retained fraction from the cation exchanger, in Fractogel EMD
DEAE 650 M (1.8 × 5 cm). Both separations (B,C) were done at a flow rate of 1 mL/min using a
400-mL gradient, from 0.01 mol/L to 1 mol/L ammonium acetate. Eighty fractions of 5 mL each were
collected in every chromatographic separation. Dashed lines in the ion-exchange chromatographic
profiles represent the gradient of ammonium acetate. Fractions exhibiting toxicity to crabs were named
I, II, III, and IV. The pools of fractions that inhibited acid-sensing ion channels are shown in both
gel-filtration and cation-exchange chromatographic profiles, according to previous results with the
same P. crucifer homogenate, using identical conditions [6]. PhcrTx1, an acid-sensing ion channel toxin
from P. crucifer [6], eluted inhibiting pools of chromatographic fractions in the ASICs, as shown in
(A,B). As shown, the crab-paralyzing zone and the ASICs inhibition zone barely overlapped in the
gel filtration profile (A); and completely separated from each other in the cation-exchange profile
(B). PhcrTx1 is not present among the crab-paralyzing chromatographic fractions isolated from the
ion-exchange chromatographic separations.
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Figure 2. Reversed-phase chromatographic profiles of crab-paralyzing fractions from ion-exchange 
chromatography. (A,B) Reversed-phase chromatographic profiles of fractions I and II previously 
separated from cation-exchange chromatography, respectively; (C,D) Reversed-phase 
chromatographic profiles of fractions III and IV previously separated from anion-exchange 
chromatography, respectively. Conditions: Hypersil H5 ODS column (4.6 × 250 mm), flow rate 0.8 
mL/min, linear gradient from 0 to 80% B in 80 min. Chromatographic fractions showing toxicity to 
crabs are indicated in the figure (1 to 16); (E,F) Reversed-phase chromatographic purification of 
fraction number 5. Conditions: Discovery RPC18 HPLC column (4.6 × 250 mm), flow rate of 1 mL/min, 
gradient from 10 to 20% B in 5 min, followed by 20 to 30% in 50 min. The pure toxin was named 
PhcrTx2. The dashed line in every chromatographic profile represents the gradient of acetonitrile. The 
asterisk (*) in (A–F) represent the point where PhcrTx1 elutes in the same chromatographic conditions, 
according to previous results [6]. 
2.2. Biological Evaluation of PhcrTx2 
2.2.1. Crab Toxicity Assay 
PhcrTx2 was evaluated by injecting several doses (62.5 µg/kg, 125 µg/kg, 250 µg/kg, 500 µg/kg, 
1000 µg/kg, 2000 µg/kg, and 4000 µg/kg) to groups of six crabs. The number (and percentage) of 
paralyzed crabs was 0 (0%), 0 (0%), 1 (16.7%), 2 (33.3%), 4 (66.7%), 5 (83.3%), and 6 (100%) out of 6, 
for every mentioned dose, respectively. The toxin was not lethal, but only paralyzing, with an ED50 = 
707 µg/kg (see Supplementary Figure S1). The onset of the tetanic paralysis was observed after 30 
min of toxin administration. After two hours, the crabs remained upward facing and showing 
uncoordinated movements of legs. 
2.2.2. Effects of PhcrTx2 on Native Nav, Kv and Glutamate-Gated Currents 
In the toxicity assays performed on crabs Uca thayeri, PhcrTx2 was not lethal but only paralyzing, 
indicating that it is most probably not acting on Nav, taking into account that Nav sea anemone toxins 
Figure 2. Reversed-phase chromatographic profiles of crab-paralyzing fractions from ion-exchange
chromatography. (A,B) Reversed-phase chromatographic profiles of fractions I and II previously
separated from cation-exchange chromatography, respectively; (C,D) Reversed-phase chromatographic
profiles of fractions III and IV previously separated from anion-exchange chromatography, respectively.
Conditions: Hypersil H5 ODS column (4.6 × 250 mm), flow rate 0.8 mL/min, linear gradient from
0 to 80% B in 80 min. Chromatographic fractions showing toxicity to crabs are indicated in the
figure (1 to 16); (E,F) Reversed-phase chromatographic purification of fraction number 5. Conditions:
Discovery RPC18 HPLC column (4.6 × 250 mm), flow rate of 1 mL/min, gradient from 10 to 20% B in
5 min, followed by 20 to 30% in 50 min. The pure toxin was named PhcrTx2. The dashed line in every
chromatographic profile represents the gradient of acetonitrile. The asterisk (*) in (A–F) represent the
point where PhcrTx1 elutes in the same chromatographic conditions, according to previous results [6].
2.2. Biological Evaluation of PhcrTx2
2.2.1. Crab Toxicity Assay
PhcrTx2 was evaluated by injecting several doses (62.5 µg/kg, 125 µg/kg, 250 µg/kg, 500 µg/kg,
1000 µg/kg, 2000 µg/kg, and 4000 µg/kg) to groups of six crabs. The number (and percentage) of
paralyzed crabs was 0 (0%), 0 (0%), 1 (16.7%), 2 (33.3%), 4 (66.7%), 5 (83.3%), and 6 (100%) out of
6, for every mentioned dose, respectively. The toxin was not lethal, but only paralyzing, with an
ED50 = 707 µg/kg (see Supplementary Figure S1). The onset of the tetanic paralysis was observed
after 30 min of toxin administration. After two hours, the crabs remained upward facing and showing
uncoordinated movements of legs.
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2.2.2. Effects of PhcrTx2 on Native Nav, Kv and Glutamate-Gated Currents
In the toxicity assays performed on crabs Uca thayeri, PhcrTx2 was not lethal but only paralyzing,
indicating that it is most probably not acting on Nav, taking into account that Nav sea anemone toxins
are lethal to crabs. For example, toxins RpI, II, III, and IV (from Radianthus paumotensis), are lethal
to crabs, with an LD50 in the range between 10 µg/kg and 90 µg/kg, [26]; AETX II and III (from
Anemonia erythraea) have LD50 values of 0.53 µg/kg and 0.28 µg/kg, respectively [16]; Am I (from
Antheopsis maculata) has an LD50 of 830 mg/kg [21]. Also, the toxicity signs induced by PhcrTx2 differ
from those caused by Nav toxins, by its late appearance and lower intensity. Hence, considering that
crustaceans have a glutamatergic neuromuscular junction, and they are habitual preys of sea anemones,
we evaluated the glutamate-induced responses in snail neurons.
Additionally, given that many sea anemone (including crab-paralyzing) toxins show activity
on mammalian ion channels, mainly by inhibiting voltage-gated potassium channels [34,35] or by
delaying the inactivation of voltage-gated sodium channels [36,37], we carried out an additional set of
experiments to evaluate the PhcrTx2 action on voltage-activated Na+ and K+ currents in rat dorsal
root ganglion (DRG) neurons. Although some sea anemone peptides have been found to be ASIC
toxins [4,6,38], PhcrTx2 is unlikely to have activity on acid-sensing ion channels from rat dorsal root
ganglion neurons. The updated Figure 1B shows that the crab-paralyzing zone (where PhcrTx2 elutes)
and the ASIC inhibition zone (where PhcrTx1 eluted in identical conditions [6]) in the cation-exchange
chromatography are completely separated. Therefore, PhcrTx2 and the other crab-paralyzing basic
peptides are not likely to exhibit ASIC inhibitory activity. Therefore, PhcrTx2 was not evaluated on
these ion channels.
PhcrTx2 Evaluation on Snail Neurons
Recordings of the glutamate-evoked currents were performed on cultured isolated neurons from
the land snail Helix aspersa. The neurons (n = 27) had a capacitance of 55 ± 14.6 pF, corresponding to
an approximate cell diameter of 24–53 µm (mean = 42 ± 6 µm). In snail neurons voltage-clamped at
negative membrane potentials (−100 mV), glutamate 1 mM (5 s) produced an inward current that
shows a fast activation, followed by a desensitization phase that could have a variable steady-state
component. We carried out a group of experiments to study glutamate-evoked currents in snail neurons
(n = 5). For this purpose, 1-mM glutamate currents were elicited at different membrane potentials from
−100 mV to +80 mV (Figure 3A); the largest current was obtained at a holding potential of −100 mV
(average values about 2.6 ± 1.4 nA). The current had an average reversal potential close to 0 mV,
from which the current increased until reaching a value of 0.3 ± 0.1 nA at 80 mV. The dose responses
curves and all of the results that are shown and discussed in this article were consequently done at a
holding potential of −100 mV.
The reversal potential of the glutamate-evoked currents was around zero (Figure 3A).
The sustained application of PhcrTx2 produced a significant decrease of the peak current (p ≤ 0.05,
Student’s t-test) in the concentration range between 3 µM and 30 µM (n = 23). The inhibitory effect was
concentration-dependent (Figure 3B). The concentration-response relationship had an IC50 of 4.7 µM.
At 3 µM, the closest value to the IC50 tested, the inhibition was statistically significant (p≤ 0.05, Student
t-test), and it was about 20.4 ± 5.3% (n = 8, p = 0.03), while the maximum inhibition observed at the
highest concentration (30 µM) was about 37.5 ± 8.1% (n = 7, p = 0.01). The inhibitory effect on the peak
current was very fast, reaching stability within about 2 min, and was fully reversible after washing
the preparation (between the first and the second minute, Figure 3C). The sustained component
and the current desensitization rate were not significantly affected at any toxin concentration tested;
for example, at 3 µM, the τdes in control was 174.7 ± 50.6 ms, whereas τdes in the presence of a toxin
was 249.2 ± 60.5 ms, p > 0.05, Student t-test, n = 9.
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Figure 3. Effect of PhcrTx2 on a glutamate-evoked current in isolated snail neurons. (A) Glutamate-
evoked (at 1 mM of Glu) currents registered at different holding potentials (from −100 mV to +80 mV) 
show a current reversal at about 0 mV, indicating that it most probably is a non-selective cation 
permeant channel; (B) Concentration-response relationship of the inhibitory effect of PhcrTx2 on 
glutamate-gated currents. Data were fitted by a dose-response function with an IC50 of 4.7 µM. Each 
point represents the mean ± SE from four to seven neurons; (C) Representative current traces elicited 
by glutamate (1 mM) under control condition, in the presence of 30 µM PhcrTx2, and after washout 
of the toxin. 
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in the concentration range from 3 µM to 30 µM showed the effects to be highly variable, and did not 
reach statistical significance. For example, 10 µM of toxin produced a significant decrease in the K+ 
current amplitude at the peak and at the steady state of 13.9 ± 2.1% (p = 0.001) and 16.0 ± 4.8% (p = 
0.002), respectively. However, the effect at 30 µM was significant neither on the peak current nor on 
the steady state current. 
PhcrTx2 Evaluation on Rat DRG Neurons 
The action of PhcrTx2 was also evaluated on the voltage-dependent Na+ current in DRG neurons 
(Supplementary Figure S2A). The toxin caused a decrease in the amplitude of the peak current at 
concentration values between 1–10 µM, with an IC50 of 0.9 ± 0.2 µM (Supplementary Figure S2B). The 
maximal effect of the toxin on the Na+ current was 16%; this action was partially reversible after 
washout (≈90%). No significant effect was observed on the time course of inactivation for any of the 
concentrations studied.  
The perfusion of cells with 30 µM of PhcrTx2 while recording K+ currents produced an inhibition 
of the K+ currents that was concentration-dependent, with an IC50 = 6.4 ± 0.2 µM and 8.2 ± 0.7 µM for 
the peak current and steady-state current, respectively (n = 31; Supplementary Figure S2C–F). The 
maximum inhibitory effect was of 26.9 ± 4.1% in the peak current and 41.4 ± 4.8% in the steady-state 
current when PhcrTx2 30 µM was perfused. This effect was partially reversible (82%) after repeated 
washing of the preparation.  
2.2.3. Effects of PhcrTx2 on Cloned Voltage-Gated Ion Channels  
At a concentration of 5 µM, PhcrTx2 was investigated for its activity on 10 different Kv channel 
isoforms and five different Nav channel isoforms expressed in X. laevis oocytes. PhcrTx2 was tested 
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An evaluation of the effect of PhcrTx2 on voltage-gated K+ currents in snail isolated cells (n = 29)
in the concentration range from 3 µM to 30 µM showed the effects to be highly variable, and did
not reach statistical significance. For example, 10 µM of toxin produced a significant decrease in the
K+ current amplitude at the peak and at the steady state of 13.9 ± 2.1% (p = 0.001) and 16.0 ± 4.8%
(p = 0.002), respectively. However, the effect at 30 µM was significant neither on the peak current nor
on the steady state current.
PhcrTx2 Evaluation on Rat DRG Neurons
The action of PhcrTx2 was also evaluated on the voltage-dependent Na+ current in DRG neurons
(Supplementary Figure S2A). The toxin caused a decrease in the amplitude of the peak current at
concentration values between 1–10 µM, with an IC50 of 0.9 ± 0.2 µM (S pplementary Figure S2B).
The maximal effect of the toxin on the Na+ current was 16%; this action was partially reversible after
washout (≈90%). No significant effect was observed on the time course of inactivation for any of the
concentrations studied.
The perfusion of cells with 30 µM of PhcrTx2 while recording K+ currents produced an inhibition
of the K+ currents that was concentration-dependent, with an IC50 = 6.4 ± 0.2 µM an 8.2 ± 0.7 µM
for the peak current and steady-state current, respectively (n = 31; Supplementary Figure S2C–F).
The maximum inhibitory effect was of 26.9 ± 4.1% in the peak current and 41.4 ± 4.8% in the
steady-state current when PhcrTx2 30 µM was perfused. This effect was partially reversible (82%) after
repeated washing of the preparation.
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2.2.3. Effects of PhcrTx2 on Cloned Voltage-Gated Ion Channels
At a concentration of 5 µM, PhcrTx2 was investigated for its activity on 10 different Kv channel
isoforms and five different Nav channel isoforms expressed in X. laevis oocytes. PhcrTx2 was tested
against members of the Shaker (Kv1.1, Kv1.2, Kv1.3, Kv1.4, Kv1.6, and Shaker IR), Shab (Kv2.1),
Shaw (Kv3.1), Shal (Kv4.2), and Eag (Kv10.1) Kv subfamilies. Furthermore, the toxin was also tested on
Nav channel isoforms Nav1.4, Nav1.5, Nav1.6, Nav1.8, and DmNav1. No effect was observed for any
of the investigated channels (Supplementary Figure S3 and Supplementary Table S2).
2.3. PhcrTx2 Sequence and Computational Analysis
PhcrTx2 was subjected to automated N-terminal degradation, yielding a full sequence of 46 amino
acid residues, 1ALPCRCEGKTEYGDKWIFHGGCPNDYGYNDRCFMKPGSVCCYPKYE46. The protein
sequence data reported in this paper appears in the UniProt Knowledgebase under the accession
number C0HK75. Its theoretical average molecular mass of 5296.9 Da (assuming the formation of
three disulfide bridges) is very close to the experimental value of 5296.8 Da (Figure 4), as determined
by MALDI-TOF-MS.
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The PhcrTx2 3D-model generated by RaptorX, which is based on the BDS-I structure (PDB code:
1bds), showed slightly superior quality values compared to the average of the others. Most of the
sequence regions that were predicted to contain β-strands by RaptorX matched those predicted by
JNET, PSSPRED, and PSIPRED (Figure 5).The 3D model includes three antiparallel β-strands (residues
14–18 DKWIF, 30–34 DRCFM, and 37–42 GSVCCY), a loop that connects the first and second strand,
a turn between the second and third strand, and three disulfide bridges, as previously explained
(Figure 6A).
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Figure 5. Multiple sequence alignment (MAFF-LINSi) of PhcrTx2 and related sequences listed in order
of descending score, according to pairwise sequence alignments using the Smith–Waterman algorithm
(EMBOSS water tool). Dark blue columns represent the alignment of identical amino acid residues,
whereas the lighter colors represent the alignment of less conserved positions. The secondary structure
features from experimental 3D structures are represented above their corresponding sequences.
The PhcrTx2-related sequences correspond to the sea anemone toxins Am-2 (UniProtKB P69930), BDS-2
(UniProtKB P59084), BDS-1(UniProtKB P11494), BcIV (UniProtKB P84919), U-AITX-Bg1a (UniProtKB
G0W2H7), U-AITX-Bg1c (UniProtKB G0W2H9), U-AITX-Bg3d (UniProtKB G0W2I1), U-AITX-Bg1b
(UniProtKB G0W2H8), U-AITX-Bg3c (UniProtKB G0W2I0), APETx3 (UniProtKB B3EWF9), APETx1
(UniProtKB P61541), and APETx2 (UniProtKB P61542). The upper side of the figure shows the
secondary structure elements predicted for PhcrTx2 using RaptorX, JNET, PSSPRED, and PSIPRED.
The lower side of the figure shows the representative disulfide bridge pattern of the family Defensin 4,
which is Cys5-Cys42, Cys7-Cys34, and Cys24-Cys43 in the multiple sequence alignment. The same S-S
arrangement is expected for PhcrTx2, corresponding to Cys4-Cys40, Cys6-Cys32, and Cys22-Cys41 in
its sequence, which fits the pattern I-V, II-IV, III-VI found in β-defensins.
According to the evolutionary information encoded within the multiple sequence alignment,
in addition to Cys residues, several other highly conserved residues, such as Gly8, Gly13, Trp16,
Pro23, Gly27, Tyr28, and Tyr42 should play structural/functional roles. It is expected that residues
Gly and Pro contribute to the peptide conformation (structural role). Trp and Tyr residues may
have a structural role, but also may have a functional role by promoting the interaction with other
molecules such as ion channels and receptors. For the prediction of the structural or ligand-binding
role of PhcrTx2 amino acid residues, we used CLIPS-4D. This classifier predicts a role in catalysis,
ligand-binding, or protein stability in a mutually exclusively manner for each residue-position, which
is assigned a P-value that enables the statistical assessment and the selection of predictions with similar
quality. Prediction requires as input a multiple sequence alignment and a 3D structure of a protein in
PDB format, and it exploits seven sequence-based and two structure-based features. Regarding the
prediction of ligand-binding sites, the 3D structure is used to deduce the local environment of each
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residue; CLIPS-4D does not use the position of a ligand [45]. According to the classifier CLIPS-4D,
all of the highly conserved residues mentioned above, and few other less conserved residues were
predicted to have a structural (pSTRUCT > pLIG) or ligand-binding role (pLIG > pSTRUCT). More
specifically, all of the Cys residues (which are engaged in disulfide bridges)—Gly8, Gly13, Trp16, Pro23,
Gly27, Tyr28, and Gly37—should contribute to shaping the peptide structure. On the other hand,
Tyr26, Asn29, and Tyr42 were predicted to have functional roles as ligand-binding residues (Figure 6B).
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3. Discussion
Up to date, more than 30 crab-paralyzing toxins have been isolated from sea anemones. Many of
these peptides have been classified as voltage-gated sodium channel toxins, whereas few other
crab-paralyzing peptides act on different targets, such as voltage-gated potassium channels. On the
other hand, other paralyzing toxins seem to belong to new classes of toxins [21,22]. In this work,
we found a diversity of paralyzing toxins from the sea anemone P. crucifer by using a crab toxicity
assay for biological activity screening during the purification process. Sixteen chromatographic
fractions showing crab-paralyzing activity were isolated from the whole-body extract of P. crucifer.
A ne peptide toxin (PhcrTx2) was discovered from one of the crab-paralyzing fractions (Fraction 5
Figure 2A), which was selected for containing a relatively large amount of peptide, which is suitable
for further chemical and pharmacological experiments. Also, fraction 5 was not lethal to crab, and the
envenomation symptoms showed longer onset times, and were less severe than those provoked by
sodium channel toxins (which are lethal to crabs), the most studied group of crab-paralyzing toxins
from sea anemones. These facts led us to sequence PhcrTx2, and to investigate its pharmacology
in an attempt to find new molecular targets of sea anemone toxins. This study represents the first
report on paralyzing toxins from a sea anemone belonging to the family Phymanthidae. A previous
report showed the isolation and characterization of the first ICK toxin (PhcrTx1) found in sea
anemone, which is an ASIC inhibitor, and showed no paralyzing effects on crabs [6]. Although a
similar chromatographic protocol was used for isolating both toxins (PhcrTx1 and PhcrTx2), their
chro atographic behaviors are so contrasting that their purification strategy (regarding the selection
of the active fraction to be purified) completely diverged after the cation-exchange chromatographic
step (Figure 1B). Nonetheless, it is worthy to mention that both toxins also have different retention
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times in reversed-phase chromatography (Figure 2F), indicating that PhcrTx2 is more hydrophobic
than PhcrTx1. On the other hand, PhcrTx1 is a much more basic peptide (pI 10.89 > 7.61) than PhcrTx2.
3.1. P. crucifer Produces a Diversity of Crab-Paralyzing Toxins
Besides PhcrTx2, P. crucifer produces several toxins with crab-paralyzing activity. In general, two
types of envenomation signs were observed. First, fractions 1–4 and 6 provoked a lethal paralysis of
barely perceptible signs, which were clearly different from the tetanic reactions. Second, fractions 5
and 7–16 induced tetanic reactions resembling, to some degree, the effects provoked by sodium
channel toxins, although with different onset times and severity. Additionally, considering the
basic/acidic properties, molecular masses, and hydrophobicities of these toxic fractions, the results
suggest that P. crucifer produces five groups of crab-paralyzing toxins (Table 1, Supplementary Table S1).
Further experiments should be performed to reveal the molecular targets of these toxins, as well as
study the interactions between them.
For more than 40 years, the crab bioassay [17,18] has been widely used for the discovery
of sea anemone toxins that have been mostly classified as sodium channels toxins. Interestingly,
other types of peptide toxins, such as Am I and II from Antheopsis maculata [21], Gigantoxin I from
Stichodactyla gigantea [22], and SHTX I and II from Stichodacyla haddoni [20], have been discovered
through the careful observation of signs in crabs. The variety of paralyzing toxins found in our study
supports the importance of such observations to widen the application of the crab bioassay in the
discovery of new toxins and families of toxins in sea anemones.
3.2. PhcrTx2 Is a New Defensin-Like Toxin
The computational analysis (Figures 5 and 6A) indicates that PhcrTx2 is a new member of
the β-defensin-fold family of polypeptides, according to several distinctive features previously
described [44]. More specifically, PhcrTx2 should be a new member of the “Defensin 4” family
(Pfam accession: PF07936), which comprises several β-defensin-fold peptide toxins from sea anemones.
Three ligand-binding residues (Tyr26, Asn29, and Tyr42) were predicted for PhcrTx2 according
to the evolutionary information encoded within the multiple sequence alignment and the PhcrTx2
three-dimensional model. Although this proposal is based on theoretical considerations, this information
could be used in principle as a reference for structure–function analyses of recombinant or chemically
synthesized variants, to determine the functional sites of this toxin. Also, given that highly conserved
residues in a multiple sequence alignment can be of biological significance, new structural or functional
residues from toxins similar to PhcrTx2 could be identified from the multiple sequence alignment.
In addition to Cys residues, other conserved residues such as Gly9, Gly14, Trp17, Pro25, Gly29, Tyr30,
Thr31, and Tyr44 (according to the Multiple Sequence Analysis numbering in Figure 5) may play
a structural/functional role in their interaction with molecular targets, such as ion channels and
receptors. To date, few experimental studies have been reported regarding the functional residues of
these toxins; most of these studies have been focused on APETx2, [5,46–48].
3.3. PhcrTx2 Is a Crab-Paralyzing Toxin Exhibiting a Low Potency Activity on Ion Channels
Most known crab-paralyzing toxins from sea anemones have been classified into the groups of Nav
toxins. A minor group has been included among the Kv toxins, whereas other crab-paralyzing toxins
remain unclassified because of the lack of pharmacological studies to characterize their mode of action,
and the absence of sequence similarity to other groups of sea anemone toxins [49]. Although PhcrTx2
was paralyzing on U. thayeri crabs with an ED50 = 707 µg/kg, it induced no severe envenomation
signs or death, in contrast to the effects currently provoked by known sodium channel toxins from sea
anemones [27], which are potently lethal to crabs. The toxicity effects of this toxin in crabs resemble
the ones reported for Am II for Antheopsis maculata [25], whose targets remain unknown. Only a small
inhibition of Nav current was detected in DRG neurons by the toxin action. No activity of PhcrTx2
at micromolar concentrations was detected in cloned human ion channels nor in cloned insect Nav
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channel DmNav1 (data not shown), which is considered a very sensitive model for the evaluation of
crustacean toxins [50].
PhcrTx2 inhibited the Kv current with low potency and efficacy in rat DRG. On the other hand,
PhcrTx2 had no influence on a large variety of cloned human Kv channels, even at a concentration
of 5 µM. This included Kv3.1, which is inhibited by BDS-I and BDS-II [34,35]. Whether the activity
detected on native Kv currents could be linked to the paralyzing activity of PhcrTx2 is still unknown.
Sea anemones can prey on vertebrates such as fish and small invertebrates, which are mainly crabs
and molluscs. Interestingly, the pharmacology of snail neurons is similar to the pharmacology of insect
and crustacean central neurons [51]. Then, the use of snail neurons as a model for the characterization
of toxins provides an adequate system, since their ion channels could be targeted by these toxins
under natural conditions. The use of DRG neurons, despite they are very different taxonomically,
represents an important step for comparison with previous results obtained from other sea anemone
toxins [52–54]. Furthermore, depending on the route of administration, when tested in mice, some
anemone toxins may have LD50 levels that are several orders of magnitude below those obtained when
tested on crabs. For example, the RpI toxin (from Radianthus paumotensis) has an LD50 of 36 µg/kg
when tested on crabs, whereas its LD50 is only 1.5 µg/kg when injected intracisternally into mice [26];
on the other hand, Av2 (from Anemonia viridis) is highly active in both crabs and mice [55]. Thus,
DRG neurons represent a suitable model for studying the pharmacological action of anemone toxins.
According to the present results, PhcrTx2 inhibited glutamate currents in snail neurons. However,
no specific subtype of glutamate receptors was determined, and it will be of great interest to study
the toxin’s specificity in the future using different models. Although the PhcrTx2 inhibitory activity
on glutamate-gated currents exhibited low potency and efficacy, this study supports the idea of
the existence of glutamate-gated ion channel toxins in these organisms, as previous studies have
indicated through the evaluation of a semi-pure chromatographic fraction and a sea anemone crude
extract [56,57]. Thus, our results represent a step forward toward the finding of a glutamate-gated
ion channel toxin in sea anemone. It would be interesting to test other structurally related toxins
on glutamate-gated ion channels, especially Am-2 [21], which shares high sequence similarity with
PhcrTx2 and might have common targets.
On the other hand, PhcrTx2 also inhibited voltage-gated K+ channels in DRG neurons with low
potency and efficacy. DRG neurons express a wide variety of Kv channels, including those with
rapid inactivation (IKA) and delayed rectifier (IKDR) channels. In DRG neurons, we identified a
transient component that is presumably related to IKA, and a sustained component related to the
IKDR contribution. The toxin seems to affect both current components without a preferential inhibitory
activity on either of them.
The inhibition of PhcrTx2 on glutamate-gated currents in snail neurons, and also on
voltage-activated K+ currents in DRG neurons, seems to be of about similar potency and slightly
different in efficacy. PhcrTx2 also acted on voltage-dependent Na+-channels of DRG neurons but
with lower efficacy, in comparison with its effect on K+ channels. According to our results, the toxin
shows a pleomorphic action across different ion channels as it acts on voltage-dependent K+ channels,
as well as on glutamate-activated channels, although with low potency and efficacy. These facts
resemble previous results from other sea anemone toxins. PhcrTx1, the first sea anemone ICK peptide
characterized from Phymanthus crucifer, constitutes a novel acid-sensing ion channel (ASIC) inhibitor,
but it also inhibited the voltage-gated K+ currents in DRG neurons, although with lower efficacy
and potency. Studies carried out with sea anemone toxins APETx1 and APETx2, which are from a
different structural family produced by the species Anthopleura elegantissima, demonstrated their lack
of target selectivity, even though these toxins were considered highly selective for some time [5,38].
APETx2 was initially considered as a specific reversible blocker of the peak component of the ASIC3
current (IC50 = 63 nM), with no effect on the sustained component of the current. This toxin also affects
heteromeric channels that contain the ASIC3 subunit, except the ASIC2a + 3 current [38]. However,
it has been shown that APETx2 has promiscuous properties, since it partially inhibits Kv3.4 channels,
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and recognizes insect and mammalian Nav channels inhibiting the sodium conductance without
affecting the inactivation and shifting activation to a depolarizing direction [38,58]. Interestingly,
a recent study has shown that APETx2 potentiates the ASIC1b current at concentrations that are 30-fold
to 100-fold higher than the concentration inhibiting ASIC3 [59].
From a biological point of view, the simultaneous action of the toxin on different targets involved
in the basic mechanism of the function of nervous system could be a successful strategy for survival.
However, given the low potency and efficacy of PhcrTx2 action on the evaluated ion channels,
we cannot discard the possibility that the main molecular target of this toxin remains unknown.
Further studies should be designed in the future to evaluate PhcrTx2 on a larger variety of receptors
and ion channels.
4. Conclusions
In the present study, we explored the diversity of crab-paralyzing toxins from the aqueous extract
of P. crucifer. Our study represents the first report of paralyzing toxins in the species P. crucifer and its
family Phymanthidae. The careful observation of the paralysis signs, together with the biochemical
properties of the toxic chromatographic fractions, allowed predicting five groups of paralyzing toxins
in P. crucifer. Further experiments will be crucial for revealing the structure and pharmacological targets
of these molecules. PhcrTx2, a new paralyzing peptide, was isolated and characterized. This toxin
represents a new member of the defensin-fold family of peptides, and shares sequence similarity with
type 3 potassium channel toxins from sea anemones. However, its weak activity on ion channels
commonly targeted by other members of this structural group aims at the existence of other molecular
targets that should contribute to revealing the origin of the toxicity of PhcrTx2.
5. Materials and Methods
5.1. Chromatographic Separation of the Toxic Compounds
A five gram-sample of a P. crucifer freeze-dried whole homogenate prepared in a previous
work [6] was mixed with 100 mL of 0.1 M ammonium acetate (p.a, Merck, Darmstadt, Germany),
stirred for 30 min, and centrifuged at 4000 g for one hour at 4 ◦C. The supernatant (350 mg/90 mL) was
applied to a Sephadex G-50 M column (Pharmacia, Stockholm, Sweden) of dimensions 5 cm × 93 cm.
The separation was done at a flow rate of 2 mL/min using 0.1 M ammonium acetate (pH 6.96) as eluent.
Fractions of 20 mL each were collected and manually read at 280 nm in a UV-1201 spectrophotometer
(Shimadzu, Kyoto, Japan).
The biologically active sample from gel filtration was applied to a Fractogel EMD SO3− 650 M
(Merck, Darmstadt, Germany) cation-exchange column of dimensions 1.8 × 5 cm. The non-retained
fraction was applied to a Fractogel EMD DEAE 650 M (Merck, Darmstadt, Germany) anion-exchange
column of dimensions 1.8 × 5 cm. Both ion-exchange steps were performed separately under the
following conditions: a 400-mL (31 column volumes) gradient of ammonium acetate was run at a flow
rate of 1 mL/min, from 0.01 M (pH 6.90) to 1 M (pH 7.20), using a gradient mixer GM-1 (Pharmacia,
Stockholm, Sweden). Eighty fractions of 5 mL each were collected and manually read at 280 nm in
a spectrophotometer.
The biologically active samples from ion-exchange chromatography were submitted to
reversed-phase chromatography on a Hypersil H5 ODS column (Unicam, Cambridge, UK) of
dimensions 4.6 mm × 250 mm, which was previously equilibrated with solvent A, 0.1% trifluoroacetic
acid (HPLC grade, AppliChem, Darmstadt, Germany). Elution was carried out at a flow rate of
0.8 mL/min by using an ascending linear gradient of solvent B, 0.05% TFA in acetonitrile, (0–80% B in
80 min). The peptide was repurified in a Discovery RPC18 HPLC column (Supelco, Bellefonte, PA,
USA) of dimensions 4.6 mm × 250 mm, using the gradient 10–20% B in 5 min, and then 20–30% in
50 min, at the flow rate of 1 mL/min. Eluting compounds were detected at 214 nm.
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The protein content of the aqueous extract and chromatographic fractions was estimated with a
Bicinchoninic acidprotein assay kit (AppliChem, Germany) [60].
5.2. Biological Assays
5.2.1. Crab Toxicity Assay
The chromatographic fractions were assayed on male shore crabs Uca thayeri weighing 2–4 g,
according to a crab bioassay widely used for the detection of paralyzing effects induced by sea anemone
toxins [17,22]. The samples were injected (10 µL/g crab weight) into the base of the third walking
leg, at a concentration of 0.2 mg/mL (corresponding to the dose of 2000 µg/kg) for toxicity screening
purposes. Three crabs were used per sample, and the paralyzing activity was considered positive at
the inability of all of the crabs (placed upward facing) to right themselves within two hours after toxin
administration. After the observation of paralyzing effects, the crabs were killed. For the estimation
of the ED50 value, groups of six crabs were used per dose. A non-linear fit of log (dose) versus
normalized response (variable slope) was performed using GraphPad Prism version 7.03 for Windows
(GraphPad Software, La Jolla, CA, USA, www.graphpad.com).
5.2.2. Patch Clamp Experiments on Neuronal Ion Channels
The effects of PhcrTx2 were studied in isolated mammalian and snail neurons using the whole cell
patch-clamp technique. Animal care and procedures were in accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Animals. All efforts were made to minimize
animal suffering. The number of animals used for this work was kept to the minimum necessary for a
meaningful interpretation of the data.
Cell Culture of Rat Dorsal Root Ganglion (DRG) Neurons and Electrophysiological Recordings
DRG neurons from Wistar rats (P5 to P9) were isolated and cultured according to the previously
described procedure [52,61]. The rats were anesthetized and killed with an overdose of sevofluorane.
The dorsal root ganglia were isolated from the vertebral column and incubated (30 min at 37 ◦C)
in Leibovitz L15 medium (L15) (Invitrogen, Carlsbad, CA, USA) containing 1.25 mg/mL trypsin
and 1.25 mg/mL collagenase (both from Sigma-Aldrich, St. Louis, MO, USA). The ganglia were
then washed three times with sterile L15, and the cells were mechanically dissociated and plated
on glass coverslips (Corning, Corning, NY, USA) pretreated with poly-D-lysine (Sigma-Aldrich),
and placed onto 35-mm culture dishes (Corning). Neurons were incubated 4 h to 8 h in a humidified
atmosphere (95% air, 5% CO2, at 37 ◦C) in a CO2 water-jacketed incubator (Nuaire, Plymouth,
MN, USA). The medium contained L15, with 15.7 mM NaHCO3 (Merck, Naucalpan, Mexico), 10% fetal
bovine serum, 2.5 µg/mL fungizone (both from Invitrogen), 100 U/mL penicillin (Lakeside, Toluca,
Mexico), and 15.8 mM HEPES (Sigma-Aldrich).
The coverslip with attached neurons was transferred to a 500-mL perfusion chamber on the stage
of an inverted phase contrast microscope (Nikon Diaphot, Tokyo, Japan). To study the effect of the
toxin on voltage-activated Na+ and K+ currents, the cells were bathed at a rate of about 100 µL/min,
with the external solutions shown in Supplementary Table S4.
A pair of glass capillaries placed approximately 40 µm above the cell continuously microperfused
(20 µL/min) external solution or external solution plus toxin. Patch pipettes were pulled from
borosilicate glass capillaries (TW120-3; WPI, Sarasota, FL, USA) using a Flaming–Brown electrode
puller (P80/PC; Sutter Instruments, San Rafael, CA, USA). They typically had a resistance between
1–2.5 MΩ when filled with the internal solution (Supplementary Table S4). The whole-cell patch
clamp technique was used to record ionic currents with an Axopatch-1D amplifier (Molecular Devices,
Sunnyvale, CA, USA). Command pulse generation and data sampling were controlled by the PClamp
8.0 software (Molecular Devices) using a 16-bit data acquisition system (Digidata 1320A, Molecular
Devices). Signals were low-pass filtered at 5 kHz or 10 kHz, and digitized at 20 kHz. Capacitance
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and series resistance (80%) were electronically compensated. During the experiment, seal and series
resistance were monitored to guarantee stable recording conditions. The K+ currents were elicited by
a single-step voltage protocol from −100 mV (Vhold) to 0 mV during 800 ms every 8 s. Na+ currents
were elicited by pulses from −100 mV (Vhold) to −10 mV during 40 ms every 8 s. It has been
reported that activation and steady-state inactivation curves shift over time in whole-cell patch
clamp experiments [62]. The recordings were initiated 10–15 min after the whole-cell configuration
was established, in order to minimize the effects of time-dependent shifts.
To study the effects on voltage-gated Na+ and K+ currents, the toxin was ejected under pressure
using a microinjector (Baby Bee; Bass, West Lafayette, IN, USA) from a micropipette positioned in the
vicinity of the cell under recording, which was perfused with the toxin until the steady state of the
effect was reached.
The concentration-response curves were fitted to the Hill equation: Y = Ymax × xn/(kn + xn),
where Y is the effect of the substance under study, Ymax is the maximum effect, x is the concentration
of the toxin, k is the concentration that produces half the maximum effect, and n is the Hill coefficient.
To define the statistical significance, the control recordings were compared with those obtained
after toxin perfusion by using a paired Student’s t-test; a p ≤ 0.05 was considered as significant.
Unless otherwise stated, all of the numerical data are presented as the mean ± SEM.
Voltage Clamp Experiments on Isolated Snail Neurons
Experiments to study glutamate-activated currents were performed in isolated neurons of
the land snail Helix aspersa. The subesophageal mass of the snail was dissected, and put into
the Ringer solution for snails (Supplementary Table S4) containing trypsin (2 mg/mL for 30 min,
at 37 ◦C). After enzymatic treatment, the preparation was washed with normal solution for snails,
and the neurons were mechanically dissociated, plated on glass coverslips (Corning) pretreated with
poly-D-lysine (Sigma-Aldrich), and placed onto 35-mm culture dishes (Corning). Neurons were
maintained at room temperature (23–25 ◦C) for at least 30 min before using, in order to allow the
isolated cells to adhere to the coverslips. The whole-cell recording was carried out using the same
experimental conditions that were described in Section 5.2.2.
Glutamate currents were elicited by a fast glutamate application (about 40 ms) by shifting one
of the three outlets of a fast change perfusion system (SF-77B, Warner Inst., Hamden, CT, USA)
while keeping the cell at a holding potential (Vh) of −100 mV. The interval between glutamate
applications was one minute, to guarantee that the current completely recovered from desensitization.
The pH of glutamate solution was checked before each experiment to avoid the potential activation
of proton-gated currents. At the beginning of this study, experiments were designed to compare
the effect of the toxin using two application protocols. No differences were observed in the toxin’s
action (10 µM) when the toxin was preapplied 10 s before and during glutamate ejection (sustained
application), or when it was coapplied with glutamate. In the case of sustained application, we also did
not observe significant differences in the amplitude of the current between the first pulse of glutamate
and a subsequent one applied one minute later, in whose interval the perfusion of the toxin was not
suspended. In view of these results, we decided to carry out the rest of the experiments using the
co-application protocol.
The solutions used in the experiments are depicted in Supplementary Table S4. The concentration
-response curves were fitted to the Hill equation following the procedure described in Section 5.2.2.
5.2.3. Expression of Voltage-Gated Ion Channels in Xenopus laevis Oocytes and
Electrophysiological Recordings
For the expression of the voltage-gated potassium channels (Kv1.1, Kv1.2, Kv1.3, Kv1.4,
Kv1.6, Shaker IR, Kv2.1, Kv3.1, Kv4.2, Kv10.1) and voltage-gated sodium channels (Nav1.4, Nav1.5,
Nav1.6, Nav1.8 and DmNav1) in Xenopus laevis oocytes, the linearized plasmids were transcribed
using the T7 or SP6 mMESSAGE-mMACHINE transcription kit (Ambion, Foster City, CA, USA).
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The harvesting of stage V-VI oocytes from an anesthetized female Xenopus laevis frog was previously
described [63]. Oocytes were injected with 50 nL of cRNA at a concentration of 1 ng/nL using
a microinjector (Drummond Scientific, Broomall, PA, USA). The oocytes were incubated in ND96
solution (Supplementary Table S4), which was supplemented with 50 mg/L gentamycin sulfate.
The use of the frogs was in accordance with the license number LA1210239.
Two-electrode voltage-clamp recordings were performed at room temperature (18–22 ◦C) using a
Geneclamp 500 amplifier (Molecular Devices, USA) controlled by a pClamp data acquisition system
(Axon Instruments, Union City, CA, USA). Whole-cell currents from oocytes were recorded 1–4 days
after injection. Bath solution composition was ND96 (Supplementary Table S4). Voltage and current
electrodes were filled with 3 M KCl. Resistances of both electrodes were kept between 0.7–1.5 MΩ.
The elicited currents were filtered at 1 kHz, and sampled at 500 Hz using a four-pole low-pass Bessel
filter. Leak subtraction was performed using a −P/4 protocol. KV1.1–KV1.6 and Shaker IR currents
were evoked by 500 ms depolarizations to 0 mV followed by a 500 ms pulse to −50 mV, from a holding
potential of −90 mV. KV2.1, KV3.1, and KV4.2, currents were elicited by 500 ms pulses to +20 mV from
a holding potential of −90 mV.
5.3. Mass Spectrometry and N-Terminal Sequencing
The molecular mass analysis of the RP-HPLC fractions was performed with a Voyager-DE
Pro matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI–TOF–MS)
device (PerSeptive Biosystems, Framingham, MA, USA). The matrix solution was prepared with
α-cyano-4-hydroxycinnamic acid dissolved at 5 mg/mL in mass buffer (0.1% TFA in 1:1 acetonitrile/water
solution). One microliter of the sample solution and matrix solution were mixed on a 100-well
stainless steel MALDI plate. Measurements were performed in linear mode. Positive ions were
accelerated at 20 kV, and up to 100 laser shots were automatically accumulated per sample position.
Voyager RP BioSpectrometry Workstation version 3.07.1 (PerSeptive Biosystems, USA) was used as the
control software.
The peptide sample was dissolved in 10% acetonitrile in water (v/v), and spotted on a glass fiber
disk (Wako, Japan), which was pretreated with Sequa-brene (Sigma, USA). Sequences were determined
by automated Edman degradation using a ShimadzuPPSQ-30 protein sequencer (Tokyo, Japan)
according to the manufacturer’s instructions.
5.4. Computational Analyses
The amino acid sequence of PhcrTx2 was submitted to different webservers for an in silico
characterization. The software GPMAW 10.2 (http://www.welcome.to/gpmaw) [64] was used for
the theoretical calculations of the isoelectric point and average molecular mass. Sequences and the
three-dimensional (3D) structures of similar peptides were retrieved from the UniProt/Swiss-Prot
and the Protein Data Bank (PDB) databases, respectively. PSI-BLAST (NCBI BLAST 2.0) (http:
//www.ebi.ac.uk/Tools/sss/psiblast/) [65] and Pfam 31.0 (http://pfam.xfam.org/) [40] were used to
identify PhcrTx2 homologues based on sequence similarity and domain architecture, respectively.
Sequence alignments with a bit-score greater than 100 and an E-value of less than 0.001 were
considered significant. The sequences mined from Pfam were selected in order of descending
score, according to pairwise sequence alignments with PhcrTx2 using the EMBOSS water tool 6.6.0.0
(http://www.ebi.ac.uk/Tools/psa/emboss_water/) [66]. MAFFT v7 (using L-INS-i as iterative
refinement method, http://mafft.cbrc.jp/alignment/server/) [67] and Jalview 2.8.2 (http://www.
jalview.org/) [68] were used for multiple sequence alignment. Secondary structure prediction was
performed with PSSpred v3 (https://zhanglab.ccmb.med.umich.edu/PSSpred) and PSIpred v3.3
(http://bioinf.cs.ucl.ac.uk/psipred/) [69]. The three-dimensional (3D) structure of PhcrTx2 was
predicted by combining a comparative modeling strategy (i.e., SWISS-MODEL in the automated mode
at http://swissmodel.expasy.org/workspace/index.php?func=modelling_simple1&userid=USERID&
token=TOKEN [70]) with a template-free approach (i.e., Phyre2 v2.0 at http://www.sbg.bio.ic.ac.uk/
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phyre2 [71], I-Tasser v5.0 at https://zhanglab.ccmb.med.umich.edu/I-TASSER/ [72], LOMETS v4.0
at http://zhanglab.ccmb.med.umich.edu/LOMETS/ [73], and RaptorXat http://raptorx.uchicago.
edu/ [74]). The predicted 3D models of PhcrTx2 were subjected to a series of tests for evaluating
their internal consistency and reliability. Backbone conformation was evaluated by the inspection
of the Psi/Phi Ramachandran plot obtained from PROCHECK analysis [75]. Packing quality of
the 3D model was investigated by the calculation of the WHATCHECK Z-score value [76]. Lastly,
sequence–structure compatibility was evaluated by VERIFY3D [77]. PROCHECK, WHATCHECK,
and VERIFY3D were executed from the structure analysis and verification servers’ website at
UCLA (https://services.mbi.ucla.edu/SAVES/). Also, we used Qmean Z-score (https://swissmodel.
expasy.org/qmean/) for the absolute quality assessment of the peptide models [78]. CLIPS-4D
(https://bioinf.ur.de/clips4d.php) [45] was used to distinguish structurally and functionally important
residue-positions based on the multiple sequence alignment and 3D data. Swiss-PdbViewer 4.1.0
(http://www.expasy.org/spdbv/) [79] was used to visualize the PhcrTx2 3D model. The PyMOL
Molecular Graphics System, Version 1.8 Schrödinger, LLC was used to visualize the electrostatic
potential molecular surface of PhcrTx2.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/10/2/72/s1,
Figure S1: Dose-response curve of the PhcrTx2 paralyzing activity on crabs, Figure S2: PhcrTx2 action on
voltage-dependent Na+ and K+ currents in DRG neurons, Figure S3: Activity profile of PhcrTx2 on Kv and
Nav channels expressed in Xenopus laevis oocytes, Table S1: Molecular mass and retention time data of toxic
reversed-phase chromatographic fractions, Table S2: Current amplitude PhcrTx2/control, Table S3: Model quality
assessment and Table S4: Solutions used in the whole-cell patch/voltage clamp experiments.
Acknowledgments: We are grateful to Adys Palmero Colmenares, Estrella Cuquerella, and Maylín Díaz Martínez
for their technical assistance; the divers Luis Alejandre, José Ramón García and José Ramón Guerra for collecting
the sea anemone specimens, Peter Højrup for his very kind gift of a GPMAW software license, Gastón Simón and
for his advice on toxicity assays, Lászlo Béress and Michael Richardson for their technical support. AA Rodríguez
especially thanks the Alexander von Humboldt Foundation (postdoctoral fellowship 3.2-KUB/1153731 STP),
the Collaborative Research Centre 1279 funded by the German Research Foundation (DFG), the International
Foundation for Science (research grants F/4082-1, F/4082-2 and travel grant), the European Molecular Biology
Organization (fellowships 167-2007 and 126-2009), the Third World Academy of Sciences (research grant
06344-2007) and the Government of Veracruz (Mexico) for their financial support. This work was partially
supported by CONACyT grant 169835. VIEP-BUAP to ES, PROFOCIE 2015 grant and Network CYTED BIOTOX
212RT0467 (headed by Prof. Carlos Álvarez Valcárcel). AJZ is indebted to CAPES Brazilian Agency for a
post-doctoral fellowship under the Edital Toxinologia 2010. JT was supported by the following grants: G.0433.12
and GOE3414N (F.W.O. Vlaanderen), IUAP 7/10 (Inter-University Attraction Poles Program, Belgian State, Belgian
Science Policy) and OT/12/081 (KULeuven).
Author Contributions: A.A.R., A.G., E.Sa. and S.P. conceived and designed the experiments; A.A.R., A.G., E.Sa.,
S.P., A.J.Z., Y.S. and R.V. performed the experiments; A.A.R., A.G., E.Sa., S.P., A.J.Z., T.P., R.A., L.S., W.-G.F., J.T.
and E.So. analyzed the data; A.A.R., E.So., E.Sa. and A.G. and wrote the paper.
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.
References
1. Oliveira, J.S.; Fuentes-Silva, D.; King, G.F. Development of a rational nomenclature for naming peptide and
protein toxins from sea anemones. Toxicon 2012, 60, 539–550. [CrossRef] [PubMed]
2. Honma, T.; Shiomi, K. Peptide toxins in sea anemones: Structural and functional aspects. Mar. Biotechnol.
(N. Y.) 2006, 8, 1–10. [CrossRef] [PubMed]
3. Cannon, S.C. Physiologic principles underlying ion channelopathies. Neurotherapeutics 2007, 4, 174–183.
[CrossRef] [PubMed]
4. Osmakov, D.I.; Kozlov, S.A.; Andreev, Y.A.; Koshelev, S.G.; Sanamyan, N.P.; Sanamyan, K.E.; Dyachenko, I.A.;
Bondarenko, D.A.; Murashev, A.N.; Mineev, K.S.; et al. Sea anemone peptide with uncommon beta-hairpin
structure inhibits acid-sensing ion channel 3 (asic3) and reveals analgesic activity. J. Biol. Chem. 2013, 288,
23116–23127. [CrossRef] [PubMed]
Toxins 2018, 10, 72 19 of 22
5. Peigneur, S.; Beress, L.; Moller, C.; Mari, F.; Forssmann, W.G.; Tytgat, J. A natural point mutation changes both
target selectivity and mechanism of action of sea anemone toxins. FASEB J. 2012, 26, 5141–5151. [CrossRef]
[PubMed]
6. Rodriguez, A.A.; Salceda, E.; Garateix, A.G.; Zaharenko, A.J.; Peigneur, S.; Lopez, O.; Pons, T.; Richardson, M.;
Diaz, M.; Hernandez, Y.; et al. A novel sea anemone peptide that inhibits acid-sensing ion channels. Peptides
2014, 53, 3–12. [CrossRef] [PubMed]
7. Putnam, N.H.; Srivastava, M.; Hellsten, U.; Dirks, B.; Chapman, J.; Salamov, A.; Terry, A.; Shapiro, H.;
Lindquist, E.; Kapitonov, V.V.; et al. Sea anemone genome reveals ancestral eumetazoan gene repertoire and
genomic organization. Science 2007, 317, 86–94. [CrossRef] [PubMed]
8. Sabourault, C.; Ganot, P.; Deleury, E.; Allemand, D.; Furla, P. Comprehensive est analysis of the symbiotic
sea anemone, Anemonia viridis. BMC Genom. 2009, 10, 333. [CrossRef] [PubMed]
9. Cassoli, J.S.; Verano-Braga, T.; Oliveira, J.S.; Montandon, G.G.; Cologna, C.T.; Peigneur, S.; Pimenta, A.M.;
Kjeldsen, F.; Roepstorff, P.; Tytgat, J.; et al. The proteomic profile of Stichodactyla duerdeni secretion reveals
the presence of a novel o-linked glycopeptide. J. Proteom. 2013, 87, 89–102. [CrossRef] [PubMed]
10. Kozlov, S.; Grishin, E. The mining of toxin-like polypeptides from est database by single residue distribution
analysis. BMC Genom. 2011, 12, 88. [CrossRef] [PubMed]
11. Moran, Y.; Praher, D.; Schlesinger, A.; Ayalon, A.; Tal, Y.; Technau, U. Analysis of soluble protein contents
from the nematocysts of a model sea anemone sheds light on venom evolution. Mar. Biotechnol. (N. Y.) 2013,
15, 329–339. [CrossRef] [PubMed]
12. Zaharenko, A.J.; Ferreira, W.A., Jr.; Oliveira, J.S.; Richardson, M.; Pimenta, D.C.; Konno, K.; Portaro, F.C.; de
Freitas, J.C. Proteomics of the neurotoxic fraction from the sea anemone Bunodosoma cangicum venom: Novel
peptides belonging to new classes of toxins. Comp. Biochem. Physiol. Part D Genom. Proteom. 2008, 3, 219–225.
[CrossRef] [PubMed]
13. Rodriguez, A.A.; Cassoli, J.S.; Sa, F.; Dong, Z.Q.; de Freitas, J.C.; Pimenta, A.M.; de Lima, M.E.; Konno, K.;
Lee, S.M.; Garateix, A.; et al. Peptide fingerprinting of the neurotoxic fractions isolated from the secretions of
sea anemones Stichodactyla helianthus and Bunodosoma granulifera. New members of the apetx-like family
identified by a 454 pyrosequencing approach. Peptides 2012, 34, 26–38. [CrossRef] [PubMed]
14. Madio, B.; Undheim, E.A.B.; King, G.F. Revisiting venom of the sea anemone Stichodactyla haddoni: Omics
techniques reveal the complete toxin arsenal of a well-studied sea anemone genus. J. Proteom. 2017, 166,
83–92. [CrossRef] [PubMed]
15. Orts, D.J.; Moran, Y.; Cologna, C.T.; Peigneur, S.; Madio, B.; Praher, D.; Quinton, L.; De Pauw, E.; Bicudo, J.E.;
Tytgat, J.; et al. Bcstx3 is a founder of a novel sea anemone toxin family of potassium channel blocker. FEBS J.
2013, 280, 4839–4852. [CrossRef] [PubMed]
16. Shiomi, K.; Qian, W.H.; Lin, X.Y.; Shimakura, K.; Nagashima, Y.; Ishida, M. Novel polypeptide toxins
with crab lethality from the sea anemone anemonia erythraea. Biochim. Biophys. Acta 1997, 1335, 191–198.
[CrossRef]
17. Béress, L.; Béress, R. Reinigung zweier krabbenlähmender toxine aus der seeanemone Anemonia sulcata.
Kiel. Meeresforsch 1971, 27, 117–127.
18. Shapiro, B.I. Purification of a toxin from tentacles of the anemone Condylactis gigantea. Toxicon 1968, 5,
253–259. [CrossRef]
19. Maeda, M.; Honma, T.; Shiomi, K. Isolation and cdna cloning of type 2 sodium channel peptide toxins from
three species of sea anemones (Cryptodendrum adhaesivum, Heterodactyla hemprichii and Thalassianthus aster)
belonging to the family thalassianthidae. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2010, 157, 389–393.
[CrossRef] [PubMed]
20. Honma, T.; Kawahata, S.; Ishida, M.; Nagai, H.; Nagashima, Y.; Shiomi, K. Novel peptide toxins from the sea
anemone Stichodactyla haddoni. Peptides 2008, 29, 536–544. [CrossRef] [PubMed]
21. Honma, T.; Hasegawa, Y.; Ishida, M.; Nagai, H.; Nagashima, Y.; Shiomi, K. Isolation and molecular cloning of
novel peptide toxins from the sea anemone Antheopsis maculata. Toxicon 2005, 45, 33–41. [CrossRef] [PubMed]
22. Shiomi, K.; Honma, T.; Ide, M.; Nagashima, Y.; Ishida, M.; Chino, M. An epidermal growth factor-like
toxin and two sodium channel toxins from the sea anemone Stichodactyla gigantea. Toxicon 2003, 41, 229–236.
[CrossRef]
Toxins 2018, 10, 72 20 of 22
23. Bruhn, T.; Schaller, C.; Schulze, C.; Sanchez-Rodriguez, J.; Dannmeier, C.; Ravens, U.; Heubach, J.F.;
Eckhardt, K.; Schmidtmayer, J.; Schmidt, H.; et al. Isolation and characterisation of five neurotoxic
and cardiotoxic polypeptides from the sea anemone Anthopleura elegantissima. Toxicon 2001, 39, 693–702.
[CrossRef]
24. Ishida, M.; Yokoyama, A.; Shimakura, K.; Nagashima, Y.; Shiomi, K. Halcurin, a polypeptide toxin from the
sea anemone Halcurias sp., with a structural resemblance to type 1 and 2 toxins. Toxicon 1997, 35, 537–544.
[CrossRef]
25. Lin, X.Y.; Ishida, M.; Nagashima, Y.; Shiomi, K. A polypeptide toxin in the sea anemone Actinia equina
homologous with other sea anemone sodium channel toxins: Isolation and amino acid sequence. Toxicon
1996, 34, 57–65. [CrossRef]
26. Schweitz, H.; Bidard, J.N.; Frelin, C.; Pauron, D.; Vijverberg, H.P.; Mahasneh, D.M.; Lazdunski, M.; Vilbois, F.;
Tsugita, A. Purification, sequence, and pharmacological properties of sea anemone toxins from radianthus
paumotensis. A new class of sea anemone toxins acting on the sodium channel. Biochemistry 1985, 24,
3554–3561. [CrossRef] [PubMed]
27. Ständker, L.; Beress, L.; Garateix, A.; Christ, T.; Ravens, U.; Salceda, E.; Soto, E.; John, H.; Forssmann, W.G.;
Aneiros, A. A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation.
Toxicon 2006, 48, 211–220. [CrossRef] [PubMed]
28. Shiomi, K. Novel peptide toxins recently isolated from sea anemones. Toxicon 2009, 54, 1112–1118. [CrossRef]
[PubMed]
29. Takeuchi, A.; Takeuchi, N. The effect on crayfish muscle of iontophoretically applied glutamate. J. Physiol.
1964, 170, 296–317. [CrossRef] [PubMed]
30. Garateix, A.; Flores, A.; Garcia-Andrade, J.M.; Palmero, A.; Aneiros, A.; Vega, R.; Soto, E. Antagonism of
glutamate receptors by a chromatographic fraction from the exudate of the sea anemone Phyllactis flosculifera.
Toxicon 1996, 34, 443–450. [CrossRef]
31. Lewis, R.J.; Dutertre, S.; Vetter, I.; Christie, M.J. Conus venom peptide pharmacology. Pharmacol. Rev. 2012,
64, 259–298. [CrossRef] [PubMed]
32. De Figueiredo, S.G.; de Lima, M.E.; Nascimento Cordeiro, M.; Diniz, C.R.; Patten, D.; Halliwell, R.F.; Gilroy, J.;
Richardson, M. Purification and amino acid sequence of a highly insecticidal toxin from the venom of the
brazilian spider Phoneutria nigriventer which inhibits nmda-evoked currents in rat hippocampal neurones.
Toxicon 2001, 39, 309–317. [CrossRef]
33. Rodriguez, A.A.; Standker, L.; Zaharenko, A.J.; Garateix, A.G.; Forssmann, W.G.; Beress, L.; Valdes, O.;
Hernandez, Y.; Laguna, A. Combining multidimensional liquid chromatography and maldi-tof-ms for the
fingerprint analysis of secreted peptides from the unexplored sea anemone species Phymanthus crucifer.
J. Chromatogr. B Anal. Technol. Biomed. Life. Sci. 2012, 903, 30–39. [CrossRef] [PubMed]
34. Yeung, S.Y.; Thompson, D.; Wang, Z.; Fedida, D.; Robertson, B. Modulation of kv3 subfamily potassium
currents by the sea anemone toxin bds: Significance for cns and biophysical studies. J. Neurosci. 2005, 25,
8735–8745. [CrossRef] [PubMed]
35. Diochot, S.; Schweitz, H.; Beress, L.; Lazdunski, M. Sea anemone peptides with a specific blocking activity
against the fast inactivating potassium channel kv3.4. J. Biol. Chem. 1998, 273, 6744–6749. [CrossRef]
[PubMed]
36. Liu, P.; Jo, S.; Bean, B.P. Modulation of neuronal sodium channels by the sea anemone peptide bds-i.
J. Neurophysiol. 2012, 107, 3155–3167. [CrossRef] [PubMed]
37. Llewellyn, L.E.; Norton, R.S. Binding of the sea anemone polypeptide bds ii to the voltage-gated sodium
channel. Biochem. Int. 1991, 24, 937–946. [PubMed]
38. Diochot, S.; Baron, A.; Rash, L.D.; Deval, E.; Escoubas, P.; Scarzello, S.; Salinas, M.; Lazdunski, M. A new sea
anemone peptide, apetx2, inhibits asic3, a major acid-sensitive channel in sensory neurons. EMBO J. 2004,
23, 1516–1525. [CrossRef] [PubMed]
39. Driscoll, P.C.; Gronenborn, A.M.; Beress, L.; Clore, G.M. Determination of the three-dimensional solution
structure of the antihypertensive and antiviral protein bds-i from the sea anemone Anemonia sulcata:
A study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing.
Biochemistry 1989, 28, 2188–2198. [CrossRef] [PubMed]
Toxins 2018, 10, 72 21 of 22
40. Punta, M.; Coggill, P.C.; Eberhardt, R.Y.; Mistry, J.; Tate, J.; Boursnell, C.; Pang, N.; Forslund, K.; Ceric, G.;
Clements, J.; et al. The pfam protein families database. Nucleic Acids Res. 2012, 40, D290–D301. [CrossRef]
[PubMed]
41. Chagot, B.; Diochot, S.; Pimentel, C.; Lazdunski, M.; Darbon, H. Solution structure of apetx1 from the sea
anemone Anthopleura elegantissima: A new fold for an herg toxin. Proteins 2005, 59, 380–386. [CrossRef]
[PubMed]
42. Diochot, S.; Loret, E.; Bruhn, T.; Beress, L.; Lazdunski, M. Apetx1, a new toxin from the sea anemone
Anthopleura elegantissima, blocks voltage-gated human ether-a-go-go-related gene potassium channels.
Mol. Pharmacol. 2003, 64, 59–69. [CrossRef] [PubMed]
43. Chagot, B.; Escoubas, P.; Diochot, S.; Bernard, C.; Lazdunski, M.; Darbon, H. Solution structure of apetx2,
a specific peptide inhibitor of asic3 proton-gated channels. Protein Sci. 2005, 14, 2003–2010. [CrossRef]
[PubMed]
44. Torres, A.M.; Kuchel, P.W. The beta-defensin-fold family of polypeptides. Toxicon 2004, 44, 581–588.
[CrossRef] [PubMed]
45. Janda, J.O.; Meier, A.; Merkl, R. Clips-4d: A classifier that distinguishes structurally and functionally
important residue-positions based on sequence and 3d data. Bioinformatics 2013, 29, 3029–3035. [CrossRef]
[PubMed]
46. Anangi, R.; Rash, L.D.; Mobli, M.; King, G.F. Functional expression in Escherichia coli of the disulfide-rich sea
anemone peptide apetx2, a potent blocker of acid-sensing ion channel 3. Mar. Drugs 2012, 10, 1605–1618.
[CrossRef] [PubMed]
47. Anangi, R.; Chen, C.C.; Lin, Y.W.; Cheng, Y.R.; Cheng, C.H.; Chen, Y.C.; Chu, Y.P.; Chuang, W.J. Expression
in Pichia pastoris and characterization of apetx2, a specific inhibitor of acid sensing ion channel 3. Toxicon
2010, 56, 1388–1397. [CrossRef] [PubMed]
48. Jensen, J.E.; Mobli, M.; Brust, A.; Alewood, P.F.; King, G.F.; Rash, L.D. Cyclisation increases the stability of
the sea anemone peptide apetx2 but decreases its activity at acid-sensing ion channel 3. Mar. Drugs 2012, 10,
1511–1527. [CrossRef] [PubMed]
49. Oliveira, J.S.; Fuentes-Silva, D.; Zaharenko, A.J. Sea anemone peptides. Biological activities,
structure-function relationships and phylogenetic aspects. In Animal Toxins: State of the Art. Perspective
in Health and Biotechnology, 1st ed.; de Lima, M.E., Pimenta, A.M., Martin-Eauclaire, M.F., Zingali, R.B.,
Rochat, H., Eds.; Editora UFMG: Belo, Horizonte, 2009.
50. Bosmans, F.; Tytgat, J. Sea anemone venom as a source of insecticidal peptides acting on voltage-gated Na+
channels. Toxicon 2007, 49, 550–560. [CrossRef] [PubMed]
51. Walker, R.J.; Roberts, C.J. The pharmacology of Limulus central neurons. Comp. Biochem. Physiol. C 1982, 72,
391–401. [CrossRef]
52. Salceda, E.; Perez-Castells, J.; Lopez-Mendez, B.; Garateix, A.; Salazar, H.; Lopez, O.; Aneiros, A.;
Standker, L.; Beress, L.; Forssmann, W.G.; et al. Cgna, a type i toxin from the giant caribbean sea anemone
Condylactis gigantea shows structural similarities to both type i and ii toxins, as well as distinctive structural
and functional properties(1). Biochem. J. 2007, 406, 67–76. [CrossRef] [PubMed]
53. Salceda, E.; Garateix, A.; Aneiros, A.; Salazar, H.; Lopez, O.; Soto, E. Effects of apc, a sea anemone toxin,
on sodium currents of mammalian neurons. Brain Res. 2006, 1110, 136–143. [CrossRef] [PubMed]
54. Garateix, A.; Salceda, E.; Menendez, R.; Regalado, E.L.; Lopez, O.; Garcia, T.; Morales, R.A.; Laguna, A.;
Thomas, O.P.; Soto, E. Antinociception produced by Thalassia testudinum extract bm-21 is mediated by the
inhibition of acid sensing ionic channels by the phenolic compound thalassiolin b. Mol. Pain 2011, 7, 10.
[CrossRef] [PubMed]
55. Moran, Y.; Gordon, D.; Gurevitz, M. Sea anemone toxins affecting voltage-gated sodium channels—Molecular
and evolutionary features. Toxicon 2009, 54, 1089–1101. [CrossRef] [PubMed]
56. Gondran, M.; Eckeli, A.L.; Migues, P.V.; Gabilan, N.H.; Rodrigues, A.L. The crude extract from the sea
anemone, Bunodosoma caissarum elicits convulsions in mice: Possible involvement of the glutamatergic
system. Toxicon 2002, 40, 1667–1674. [CrossRef]
57. Garateix, A.; Menéndez, R.; Díaz, M.; Martínez, J.R.; Más, R. Bunodosoma granulifera: Una especie de interés
para el estudio de las neurotoxinas de anémonas. Biología 1987, 1, 15–26.
58. Blanchard, M.G.; Rash, L.D.; Kellenberger, S. Inhibition of voltage-gated Na+ currents in sensory neurones
by the sea anemone toxin apetx2. Br. J. Pharmacol. 2012, 165, 2167–2177. [CrossRef] [PubMed]
Toxins 2018, 10, 72 22 of 22
59. Lee, J.Y.P.; Saez, N.J.; Cristofori-Armstrong, B.; Anangi, R.; King, G.F.; Smith, M.T.; Rash, L.D. Inhibition of
acid-sensing ion channels by diminazene and apetx2 evoke partial and highly variable antihyperalgesia in a
rat model of inflammatory pain. Br. J. Pharmacol. 2017. [CrossRef] [PubMed]
60. Smith, P.K.; Krohn, R.I.; Hermanson, G.T.; Mallia, A.K.; Gartner, F.H.; Provenzano, M.D.; Fujimoto, E.K.;
Goeke, N.M.; Olson, B.J.; Kenk, D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985,
150, 76–85. [CrossRef]
61. Garza, A.; Lopez-Ramirez, O.; Vega, R.; Soto, E. The aminoglycosides modulate the acid-sensing ionic
channel currents in dorsal root ganglion neurons from the rat. J. Pharmacol. Exp. Ther. 2010, 332, 489–499.
[CrossRef] [PubMed]
62. Salceda, E.; Lopez, O.; Zaharenko, A.J.; Garateix, A.; Soto, E. The sea anemone Bunodosoma caissarum
toxin bciii modulates the sodium current kinetics of rat dorsal root ganglia neurons and is displaced in a
voltage-dependent manner. Peptides 2010, 31, 412–418. [CrossRef] [PubMed]
63. Liman, E.R.; Tytgat, J.; Hess, P. Subunit stoichiometry of a mammalian K+ channel determined by construction
of multimeric cdnas. Neuron 1992, 9, 861–871. [CrossRef]
64. Peri, S.; Steen, H.; Pandey, A. Gpmaw—A software tool for analyzing proteins and peptides. Trends Biochem. Sci.
2001, 26, 687–689. [CrossRef]
65. Altschul, S.F.; Madden, T.L.; Schaffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D.J. Gapped blast and
psi-blast: A new generation of protein database search programs. Nucleic Acids Res. 1997, 25, 3389–3402.
[CrossRef] [PubMed]
66. McWilliam, H.; Li, W.; Uludag, M.; Squizzato, S.; Park, Y.M.; Buso, N.; Cowley, A.P.; Lopez, R. Analysis tool
web services from the embl-ebi. Nucleic Acids Res. 2013, 41, W597–W600. [CrossRef] [PubMed]
67. Katoh, K.; Standley, D.M. Mafft multiple sequence alignment software version 7: Improvements in
performance and usability. Mol. Biol. Evol. 2013, 30, 772–780. [CrossRef] [PubMed]
68. Waterhouse, A.M.; Procter, J.B.; Martin, D.M.; Clamp, M.; Barton, G.J. Jalview version 2—A multiple sequence
alignment editor and analysis workbench. Bioinformatics 2009, 25, 1189–1191. [CrossRef] [PubMed]
69. Jones, D.T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol.
1999, 292, 195–502. [CrossRef] [PubMed]
70. Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The swiss-model workspace: A web-based environment for
protein structure homology modelling. Bioinformatics 2006, 22, 195–201. [CrossRef] [PubMed]
71. Kelley, L.A.; Sternberg, M.J. Protein structure prediction on the web: A case study using the phyre server.
Nat. Protoc. 2009, 4, 363–371. [CrossRef] [PubMed]
72. Zhang, Y. I-tasser server for protein 3d structure prediction. BMC Bioinform. 2008, 9, 40. [CrossRef] [PubMed]
73. Wu, S.; Zhang, Y. Lomets: A local meta-threading-server for protein structure prediction. Nucleic Acids Res.
2007, 35, 3375–3382. [CrossRef] [PubMed]
74. Kallberg, M.; Wang, H.; Wang, S.; Peng, J.; Wang, Z.; Lu, H.; Xu, J. Template-based protein structure modeling
using the raptorx web server. Nat. Protoc. 2012, 7, 1511–1522. [CrossRef] [PubMed]
75. Laskowski, R.A.; Rullmannn, J.A.; MacArthur, M.W.; Kaptein, R.; Thornton, J.M. Aqua and procheck-nmr:
Programs for checking the quality of protein structures solved by nmr. J. Biomol. NMR 1996, 8, 477–486.
[CrossRef] [PubMed]
76. Hooft, R.W.; Vriend, G.; Sander, C.; Abola, E.E. Errors in protein structures. Nature 1996, 381, 272. [CrossRef]
[PubMed]
77. Bowie, J.U.; Luthy, R.; Eisenberg, D. A method to identify protein sequences that fold into a known
three-dimensional structure. Science 1991, 253, 164–170. [CrossRef] [PubMed]
78. Benkert, P.; Biasini, M.; Schwede, T. Toward the estimation of the absolute quality of individual protein
structure models. Bioinformatics 2011, 27, 343–350. [CrossRef] [PubMed]
79. Guex, N.; Peitsch, M.C. Swiss-model and the swiss-pdbviewer: An environment for comparative protein
modeling. Electrophoresis 1997, 18, 2714–2723. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
